The LaJoie Group seeks to define the molecular mechanisms underlying diseases of the nuclear envelope. To address these questions, we integrate approaches from biochemistry, structural proteomics, and cell biology. By working in disease-relevant cell types, we aim to investigate fundamental questions in cell biology within the physiological contexts in which these diseases arise, as different […]